Skip to content

Evaluating Therapeutic effects of Wrist splint in patients with Carpal Tunnel Syndrome under treatment with Ibuprofen

Evaluating Therapeutic effects of Wrist splint in terms of EMG-NCV in patients with Carpal Tunnel Syndrome (CTS) under treatment with Ibuprofen

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014111018063N2
Enrollment
40
Registered
2014-12-19
Start date
2014-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome. Mononeuropathies of upper limb

Interventions

Intervention 1: Control group:treated with Ibuprofen 800 mg twice a day for 6 weeks. Intervention 2: Case group: treated with Ibuprofen 800 mg twice a day with wrist splint for 6 weeks.
Treatment - Drugs
Treatment - Other
Control group:treated with Ibuprofen 800 mg twice a day for 6 weeks
Case group: treated with Ibuprofen 800 mg twice a day with wrist splint for 6 weeks.

Sponsors

Vice-chancellor for research - Birjand University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Personal consent for participation; not being pregnant or having pregnancy-induced carpal tunnel syndrome; not having carpal tunnel syndrome caused by trauma such as wrist fractures or tumor disorders; not suffering from spinal cord injuries or organic upper extremity disorders; no addiction; Exclusion criteria:Not willing for re-examination and performing laboratory tests; the inclusion of a specific organic pathology such as cancer, tumors, fractures, collagen vascular diseases such as RA, metabolic diseases such as diabetes, thyroid disorders, or other problems that interfere with the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Velocity of nerve conduction. Timepoint: before intervention - after intervention. Method of measurement: EMG-NCV.;Amplitude of nerve conduction. Timepoint: before intervention - after intervention. Method of measurement: EMG-NCV.;Latency (s) of nerve conduction. Timepoint: before intervention - after intervention. Method of measurement: EMG-NCV.;Latency (m) of nerve conduction. Timepoint: before intervention - after intervention. Method of measurement: EMG-NCV.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Rajabpour Sanati

Birjand University of Medical Sciences

ali.poursanati@bums.ac.ir; ali.poursanati@gmail.com+98 51 3234 1067

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026